ARCHIVES

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

Includes Sept. Business & Regulatory Report.

September 26, 2003